Increased prevalence of atherosclerotic wall changes in patients with hyperlipidaemia after renal transplantation

Journal of Internal Medicine

Volumn 239, Issue 2, 1996, Pages 177-180

  Jogestrand, T ^a   Fehrman Ekholm, I ^a   Angelin, B ^a   Berglund, L ^a   Gabel H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Carotid artery; Hyperlipidaemia; Intima media complex; Renal transplant recipients; Ultrasonography

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GEMFIBROZIL; PREDNISOLONE;

ADULT; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; KIDNEY TRANSPLANTATION; MALE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; CAROTID ARTERY, COMMON; DOUBLE-BLIND METHOD; FEMALE; GEMFIBROZIL; HUMANS; HYPERLIPIDEMIAS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; TUNICA INTIMA; TUNICA MEDIA;

EID: 0030041113     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Appel GA. Lipid abnormalities in renal disease. Kidney Int 1991; 39: 169-83.
2. Bittar AE, Ratcliffe PJ, Richardsson AJ, Raine AEG, Jones L, Yudkin PL et al. The prevalence of hyperlipidemia in renal transplant recipients. Transplantation 1990; 50: 987-92.
3. Mahony JF, Caterson RJ, Pollock CA, Jones M, Waugh DA, Ross Sheil AG. Coronary artery disease is the major late complication of successful cadaveric renal transplantation. Clin Transplantation 1990; 4: 129-32.
4. Fehrman-Ekholm I, Jogestrand T, Angelin B. Decreased cyclosporine levels during gemfibrozil treatment of hyperlipidemia after kidney transplantation. (Letter to the Editor) Nephron (in press).
5. Lemne C, Jogestrand T, de Faire U. Carotid intima-media thickness and plaque in borderline hypertension. Stroke 1995; 26: 34-9.
6. Cassader M, Ruiu G, Gambino R, Alemanno N, Triolo G, Pagano G. Lipoprotein-apolipoprotein changes in renal transplant recipients: a 2-year follow up. Metabolism 1991; 40: 922-5.
7. Attman PO, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 1993; 21: 573-92.
8. Steinberg D. Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis. Atherosclerosis Rev 1988; 18: 1-23.
9. Dimény E, Tufveson G, Lithelt H, Larsson E, Siegbahn A, Fellström B. The influence of pretransplant lipoprotein abnormalities on the early results of renal transplantation. Eur J Clin Invest 1993; 23: 572-9.
10. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: a new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988; 70: 253-61.
11. Wendelhag I, Wiklund O, Wikstrand J. Arterial wall thickness in familial hypercholesterolemia. Ultrasound measurement of intima-media thickness in common carotid artery. Arterioscler Thromb 1992; 12: 70-7.
12. Kronenberg F, Kathrein H, König P, Neyer U, Sturm W, Lhotta K et al. Apolipoprotein (a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease. Arterioscler Thromb 1994; 14: 1405-11.
13. Burdick L, Periti M, Salvaggio A, Bertoli S, Mangiarotti R, Castagnone D et al. Relation between carotid artery atherosclerosis and time on dialysis. A non-invasive study in vivo. Clin Nephrol 1494; 42: 121-6.
14. Craven TE, Ryu JE, Espeland MA, Kahl FR, McKinney WM, Toole JF et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study. Circulation 1990; 82: 1230-42.